2014

Trovagene to Present at Jefferies 2014 Global Healthcare Conference

SAN DIEGO, May 28, 2014 /PRNewswire/ -- Trovagene, Inc. (NASDAQ:  TROV), a developer of cell-free molecular diagnostics, today announced that Chief Financial Officer Stephen Zaniboni is scheduled to present a corporate overview at the Jefferies 2014 Global Healthcare Conference.

Trovagene is scheduled to present at the Jefferies 2014 Global Healthcare Conference at the Grand Hyatt in New York, NY on Monday , June 2, 2014 at 4:30 p.m. Mr. Zaniboni will be available for one-on-one meetings during the conference. The presentation will be webcast live at http://wsw.com/webcast/jeff82/trov and can also be accessed through the investor relations page at www.trovagene.com. A replay of the presentation will be available at www.trovagene.com and will be archived for 90 days.

About Trovagene, Inc.

Headquartered in San Diego, California, Trovagene is leveraging its proprietary technology for the detection and monitoring of cell-free DNA and RNA in urine.  The company's technology detects and quantitates oncogene mutations in cancer patients for improved disease management. Trovagene's precision cancer monitoring platform is designed to provide important clinical information beyond the current standard of care, and is protected by significant intellectual property including multiple issued patents and pending patent applications globally.

Contact






Trovagene, Inc.



Investor Relations


Media Relations

David Moskowitz and Amy Caterina

Investor Relations


Ian Stone

Account Director

Trovagene, Inc.


Canale Communications, Inc.

858-952-7593


619-849-5388

ir@trovagene.com


ian@canalecomm.com

SOURCE Trovagene, Inc.



RELATED LINKS
http://www.trovagene.com

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.